Print

Navidea Biopharmaceuticals (NEOP) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference  
2/6/2013 9:30:12 AM

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, President and Chief Executive Officer, will participate at the 15th Annual BIO CEO & Investor Conference, hosted by the Biotechnology Industry Organization (BIO), on February 11-12 at the Waldorf-Astoria in New York City. Dr. Pykett will provide an update of the Company and its development programs on Monday, February 11, 2013 at 3:30 PM EST.
//-->